HS-20197
/ Jiangsu Hansoh Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 23, 2026
A Study of HS-20197 in Participants With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=595 | Not yet recruiting | Sponsor: Hansoh BioMedical R&D Company
New P1 trial • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1